• Refine Query
  • Source
  • Publication year
  • to
  • Language
  • 6631
  • 3171
  • 1495
  • 1057
  • 473
  • 386
  • 344
  • 225
  • 215
  • 189
  • 176
  • 119
  • 50
  • 46
  • 44
  • Tagged with
  • 16420
  • 2404
  • 1809
  • 1731
  • 1538
  • 1313
  • 1285
  • 1145
  • 988
  • 951
  • 931
  • 866
  • 847
  • 817
  • 806
  • About
  • The Global ETD Search service is a free service for researchers to find electronic theses and dissertations. This service is provided by the Networked Digital Library of Theses and Dissertations.
    Our metadata is collected from universities around the world. If you manage a university/consortium/country archive and want to be added, details can be found on the NDLTD website.
51

Expressão das proteínas CD90 e HIF-1 alfa no microambiente tumoral do carcinoma espinocelular de boca / Protein expression of CD90 and HIFf-1 alpha in microenvironment tumor the squamous cell carcinoma

Ribeiro, Maisa 19 February 2015 (has links)
Submitted by Luciana Ferreira (lucgeral@gmail.com) on 2015-10-09T12:38:26Z No. of bitstreams: 2 Dissertação - Maisa Ribeiro - 2015.pdf: 1621645 bytes, checksum: 2b3a1e65f1e53b4a1264cf3febb2c630 (MD5) license_rdf: 23148 bytes, checksum: 9da0b6dfac957114c6a7714714b86306 (MD5) / Approved for entry into archive by Luciana Ferreira (lucgeral@gmail.com) on 2015-10-09T12:41:15Z (GMT) No. of bitstreams: 2 Dissertação - Maisa Ribeiro - 2015.pdf: 1621645 bytes, checksum: 2b3a1e65f1e53b4a1264cf3febb2c630 (MD5) license_rdf: 23148 bytes, checksum: 9da0b6dfac957114c6a7714714b86306 (MD5) / Made available in DSpace on 2015-10-09T12:41:15Z (GMT). No. of bitstreams: 2 Dissertação - Maisa Ribeiro - 2015.pdf: 1621645 bytes, checksum: 2b3a1e65f1e53b4a1264cf3febb2c630 (MD5) license_rdf: 23148 bytes, checksum: 9da0b6dfac957114c6a7714714b86306 (MD5) Previous issue date: 2015-02-19 / Conselho Nacional de Pesquisa e Desenvolvimento Científico e Tecnológico - CNPq / In the lesions carcinomatous, low oxygen tension plays a crucial step in the self-renewal, metastatic potential, and therapy resistance of cancers. To adapt to the hypoxic microenvironment, neoplastic cells activate hypoxia-induced factor-1 alpha (HIF-1 alpha), which may mediates invasion and metastasis. In addition, the human THY-1 (CD90) cell surface protein mediates cell adhesion expressed in stem cells, and seens to drive tumor development in some malignant tumors. The present study investigates HIF-1 alpha (n=98) and CD90 (n=97) expression in oral squamous cell carcinoma (OSCC) and metastatic lymph nodes (n=24), the intratumoral region and the invasive front, by immunohistochemistry. Furthermore, clinicopathological data revised from the medical records. In superficial OSCCs, most tumor cells overexpressed HIF-1 alpha, whereas was restricted in the intratumoral region in invasive conventional SCCs. Interestingly, metastatic lymph nodes (91.7%, p=0.001), and intratumoral regions of its corresponding primary tumors (83.3%, p<0.001) were invaded by HIF-1 alpha-positive neoplastic cells. Overall survival was poor in patients with nodal involvement. CD90 was expressed mostly in microvessels and granulocyte cells similar to mast cells. These cells expressed CD90 mostly in the peritumoral region of invasive SCC (p<0.001). Microvessels CD90 positive were higher in the intratumoral region (p=0.032). Interesting, mast cell and microvessels positively correlated in OSCC (p=0.006; r²=0.077). In conclusion, hypoxic environment may facilitate regional metastasis and serve as a potential diagnostic and prognostic marker in OSCC primary tumors. Microvessels CD90 positive seems to promote tumor growth except in BSCC. Mast cell may occur via CD90 for tumor progression. / Nas lesões carcinomatosas a baixa tensão de oxigênio desempenha um passo crucial para a auto-renovação, potencial metastático, e resistência à terapia no câncer. Para se adaptar ao ambiente hipóxico, células neoplásicas ativam o fator induzido por hipóxia-1 alfa (HIF-1 alfa), que pode facilitar a invasão e metástase. Além disso, o THY-1 (CD90) humano, uma proteína de superfície celular expressa em células estaminais, medeia a adesão celular, e parece promover o desenvolvimento em alguns tumores malignos. O presente estudo analisou a expressão das proteínas HIF-1 alfa (n = 98) e CD90 (n = 97) no carcinoma espinocelular de boca (CEC de boca) e linfonodos metastáticos (n=24), na região intratumoral e no fronte de invasão, por meio de imunoistoquímica. Além disso os dados clinicopatológicos foram revisados a partir dos prontuários médicos e a sobrevida foi analisada. No CEC microinvasivo, a maioria das células tumorais apresentaram superexpressão do HIF-1 alfa, enquanto que no CEC invasivo a superexpressão foi restrita na região intratumoral. Verificou-se que em linfonodos metastáticos (91,7%, p = 0,001), e regiões intratumorais dos seus tumores primários correspondentes (83,3%, p <0,001) houve forte expressão do HIF-1 alfa em células neoplásicas. A sobrevida global foi pior em pacientes com metástase regional. A proteína CD90 foi expressa principalmente em microvasos e células de granulócitos semelhantes aos mastócitos. Estas células expressaram CD90 principalmente na região fronte de invasão do CEC invasivo (p<0,001). A média de microvasos CD90 positivo foi maior na região intratumoral (p=0,032). Interessantemente, mastócitos e microvasos foram positivamente correlacionados no CEC de boca (p=0,006; r²=0,077). Em conclusão, o ambiente hipóxico pode facilitar metástases regionais e funcionar como um potencial marcador de diagnóstico e prognóstico em tumores primários do CEC de boca. Os microvasos CD90 positivo parecem promover o crescimento do tumor, exceto no carcinoma escamoso basalóide (CEB). Os mastócitos ativados via CD90 podem contribuir com a progressão do tumor.
52

Mecanismos reguladores da resposta inflamatória aguda sitêmica produzida pela isquemia e reperfusão intestinal em camundongos geneticamente selecionados para alta ou baixa reatividade inflamatória. / Regulatory mechanisms of systemic acute inflammation produced by intestinal ischemia and reperfusion in mice genetically selected for high or low inflammatory reactivity.

Alessandra Paes Suppa 19 June 2015 (has links)
Alterações no mecanismo de transporte de oxigênio (O2) frequentes em inflamações, infecções, tumores, transplantes e isquemia, levam a hipóxia tecidual. Espécies reativas do O2 são produzidas e citocinas inflamatórias são liberadas engatilhando uma série de eventos, os quais são amplificados após a restituição do fluxo sanguíneo resultando em inflamação sistêmica. No presente estudo, caracterizamos a regulação da Resposta Inflamatória Aguda (AIR) após indução de isquemia e reperfusão intestinal (I/Ri) e a participação do HIF-1&alpha; neste fenótipo. Camundongos selecionados para alta (AIRmax) e baixa (AIRmin) AIR foram submetidos a I/Ri e avaliados em diferentes períodos de reperfusão (0, 1, 4 e 24h). Nossos resultados demonstraram maior sensibilidade da linhagem AIRmax frente a I/Ri, confirmada por: 1) maior mobilização de neutrófilos para circulação periférica; 2) maior adesão celular e aumento da migração granulocítica no intestino e pulmão; 3) aumento da expressão de genes de citocinas e daqueles expressos em hipóxia (Tnfa, Il1, Il6 e Hif1a); 4) Translocação Bacteriana (TB); 5) maior expressão pulmonar da proteína HIF-1&alpha; e de proteínas envolvidas em processos inflamatórios tais como S100A9, Anexina 1, Profilina 1, Tropomiosina. Por outro lado, a linhagem AIRmin foi considerada pouco responsiva aos efeitos da I/Ri. Diante do exposto, nós concluímos que a sensibilidade dos camundongos AIRmax à injuria após indução de IRi está associada ao agravamento da inflamação sistemica, a qual foi determinada pela indução de HIF-1&alpha; atrelada à expressão de proteínas pró- inflamatórias e TB, indicando o compartilhamento ou a co- segregação entre os genes envolvidos na AIR e na hipóxia. / Changes in oxygen transport mechanism (O2) frequent in inflammation, infection, tumors, transplantation and ischemia, lead to tissue hypoxia. Reactive species of O2 are produced and inflammatory cytokines are released triggering a series of events, which are amplified after blood flow refund resulting in systemic inflammation. In the present study, we characterized the regulation of Acute Inflammatory Response (AIR) after intestinal ischemia and reperfusion (I/Ri) induction and the involvement of HIF-1&alpha; in this phenotype. Mice selected for high (AIRmax) and low (AIRmin) AIR were subjected to I/Ri and evaluated in different periods of reperfusion (0, 1, 4 and 24h). Our results show sensitivity of AIRmax front line I/Ri, confirmed by: 1) higher neutrophils mobilization to peripheral circulation; 2) increase in cell adhesion and granulocyte migration in lung and intestine; 3) higher expression of cytokine genes and those expressed in hypoxia (TNFa, IL-1, IL-6 and HIF1a); 4) Bacterial Translocation (BT), 5) increase in HIF-1&alpha; pulmonary protein expression and those involved in inflammatory processes such as S100A9, Annexin 1, profilin 1 Tropomyosin. On the other hand, the AIRmin line was considered unresponsive to effects of I/Ri. We concluded that the I/Ri sensitivity of the AIRmax mice were associated with worsening of systemic inflammation, which was determined by HIF-1&alpha; induction linked to the expression of pro- inflammatory proteins and TB, indicating the share and/or co-segregation of the genes involved in AIR.
53

Expressão imunohistoquímica do fator indutor de hipóxia 1-alfa (HIF-1?) em pacientes com câncer de mama localmente avançado / Immunohistochemical expression of hypoxia-inducible factor 1-alpha in locally advanced breast cancer patients

Luiz Gustavo Oliveira Brito 15 July 2010 (has links)
Objetivos: Determinar a expressão imunohistoquímica do fator indutor de hipóxia 1-alfa (HIF-1-alfa) e suas variáveis associadas em pacientes com câncer de mama localmente avançado. Pacientes e método: Vinte e sete mulheres foram biopsiadas para diagnóstico histopatológico do carcinoma mamário e submetidas a tratamento quimioterápico pré-cirúrgico. Analisou-se a associação do HIF-1-alfa com idade, tamanho tumoral, grau histológico, estadio clínico, status hormonal e axilar, resposta clínica e patológica após tratamento quimioterápico, expressão do receptor de estrogênio, progesterona e cerbB2. Resultados: A expressão de HIF-1-alfa foi presente em 66,7% das pacientes. O único fator associado à sua presença foi o status axilar positivo (p=0,02), tendo permanecido durante a análise univariada. As demais variáveis não apresentaram associação estatisticamente significante. Conclusão: Existe uma associação estatisticamente significante entre o acometimento linfonodal e a presença de HIF-1-alfa em pacientes com câncer de mama localmente avançado. / Objectives: To assess the expression of HIF-1 and its associated variables with locally advanced breast cancer (LABC) patients. Methods: Twenty-seven women were submitted to incisional biopsy for histopathological diagnosis of breast carcinoma and undertaken to neoadjuvant chemotherapy (NACT). It was studied the association of HIF-1 with age, tumoral size, histological grade, clinical stage, hormonal and axillary status, clinical and pathological response after NACT, expression of estrogen and progesterone receptors, as well as the presence of cerbB2 antigen. Results: HIF-1-alpha expression was found in 66.7% of patients. Only axillary status was the associated factor with its presence (p=0.02), and remained after univariate analysis. The others did not present any significant statistically difference. Conclusion: There is a significant statistically association between axillary status and HIF-1-alpha expression in LABC patients.
54

1-アルキルピラゾール-3-カルボキサミドを有する新規低酸素誘導因子(HIF)阻害薬に関する研究

安田, 順信 23 March 2015 (has links)
京都大学 / 0048 / 新制・課程博士 / 博士(薬科学) / 甲第18927号 / 薬科博第41号 / 新制||薬||5(附属図書館) / 31878 / 京都大学大学院薬学研究科医薬創成情報科学専攻 / (主査)教授 掛谷 秀昭, 教授 大野 浩章, 教授 高須 清誠 / 学位規則第4条第1項該当 / Doctor of Pharmaceutical Sciences / Kyoto University / DFAM
55

Hypoxia signaling in osteoblast lineage cells promotes Systemic breast cancer growth and metastasis / La signalisation HIF dans le lignage ostéoblastique affecte la croissance et la dissémination du cancer du sein de façon systémique

Devignes, Claire-Sophie 20 November 2017 (has links)
La formation de métastases osseuses implique de nombreuses interactions entre les cellules de cancer du sein et le microenvironnement osseux. Les gradients d’hypoxie et l’activation de HIF (hypoxia inducible factor) 1alpha sont essentiels au maintien de l’homéostasie osseuse. Le rôle de la signalisation HIF dans les ostéoblastes lors du processus métastatique n’a pourtant jamais été exploré. Dans cette étude, nous montrons que les cellules ostéoprogénitrices (OPC), se situent dans des niches hypoxique, et que l’activation de la signalisation HIF dans ces cellules augmente la masse osseuse et favorise les métastases osseuses du cancer sein. L’effet de la signalisation HIF dans les OPC n’est pas limité au squelette, en effet celle-ci stimule aussi la croissance des tumeurs mammaires et la dissémination tumorale dans les poumons et d’autres organes distants. Nous avons mis en évidence que la signalisation HIF dans les OPC induit l’augmentation de la concentration plasmatique de la chimiokine C-X-C motif ligand 12 (CXCL12), qui entraine une augmentation systémique de la prolifération et de la dissémination tumorale, via l’activation de son récepteur CXCR4 sur les cellules cancéreuses. Ainsi, nos résultats mettent en évidence le rôle protumorigénique de l’hypoxie dans le lignage ostéoblastique, lors de la formation de métastases osseuse, mais également par une action systémique sur les tumeurs mammaires et les métastases dans les tissus mous. Nous démontrons également que des altérations de l’anabolisme osseux peuvent affecter la progression du cancer du sein, révélant un nouveau rôle du squelette au sein du macroenvironnement tumoral. / Bone metastasis involves dynamic interplay between tumor cells and thelocal stromal environment. In bones, local hypoxia and activation of the hypoxiainducible factor (HIF)-1alpha in osteoblasts are essential to maintain skeletalhomeostasis. However, the role of osteoblast-specific HIF signaling in cancermetastasis is unknown. Here we show that osteoprogenitor cells (OPC) are locatedin hypoxic niches in the bone marrow, and that activation of HIF signaling in thesecells increases bone mass and favors breast cancer metastasis to bone locally.Remarkably, HIF signaling in osteoblast lineage cells also promotes breast cancergrowth and dissemination remotely, in the lungs and in other tissues distant frombones. Mechanistically, we found that activation of HIF signaling in OPC increasesblood levels of the chemokine C-X-C motif ligand 12 (CXCL12), which leads to asystemic increase of breast cancer cell proliferation and dissemination, throughdirect activation of the CXCR4 receptor. Hence, our data reveal a previouslyunrecognized role of the hypoxic osteogenic niche in promoting tumorigenesisbeyond the local bone microenvironment. They also indicate that alterations inbone formation can affect breast cancer progression, and support the concept thatthe skeleton is an important regulator of the systemic tumor environment.
56

THE UNDERLYING MECHANISM(S) OF FASTING INDUCED NEUROPROTECTION AFTER MODERATE TRAUMATIC BRAIN INJURY

Davis, Laurie Michelle Helene 01 January 2008 (has links)
Traumatic brain injury (TBI) is becoming a national epidemic, as it accounts for 1.5 million cases each year. This disorder affects primarily the young population and elderly. Currently, there is no treatment for TBI, which means that ~2% of the U.S. population is currently living with prolonged neurological damage and dysfunction. Recently, there have been many studies showing that TBI negatively impacts mitochondrial function. It has been proposed that in order to save the cell from destruction mitochondrial function must be preserved. The ketogenic diet, originally designed to mimic fasting physiology, is effective in treating epilepsy. Therefore, we have used fasting as a post injury treatment and attempted to elucidate its underlying mechanism. 24 hours of fasting after a moderate TBI increased tissue sparing, cognitive recovery, improved mitochondrial function, and decreased mitochondrial biomarkers of injury. Fasting results in hypoglycemia, the production of ketones, and the upregulation of free fatty acids (FFA). As such, we investigated the neuroprotective effect of hypoglycemia in the absence of fasting through insulin administration. Insulin administration was not neuroprotective and increased mortality in some treatment groups. However, ketone administration resulted in increased tissue sparing. Also, reduced reactive oxygen species (ROS) production, increased the efficiency of NADH utilization, and increased respiratory function. FFAs and uncoupling proteins (UCP) have been implicated in an endogenously regulated anti-ROS mechanism. FFAs of various chain lengths and saturation were screened for their ability to activate UCP mediated mitochondrial respiration and attenuate ROS production. We also measured FFA levels in serum, brain, and CSF after a 24 hour fast. We also used UCP2 transgenic overexpressing and knockout mice in our CCI injury model, which showed UCP2 overexpression increased tissue sparing, however UCP2 deficient mice did not show a decrease in tissue sparing, compared with their wild type littermates. Together our results indicate that post injury initiated fasting is neuroprotective and that this treatment is able to preserve mitochondrial function. Our work also indicates ketones and UCPs may be working together to preserve mitochondrial and cellular function in a concerted mechanism, and that this cooperative system is the underlying mechanism of fasting induced neuroprotection.
57

Regulatory Mechanism of Myeloid Derived Suppressor Cell Activity

Corzo, Cesar Alexander 17 June 2010 (has links)
Myeloid-derived suppressor cells (MDSC) are a major component of the immune suppressive network that develops during cancer. MDSC down-regulate immune surveillance and antitumor immunity and facilitate tumor growth. The ability of MDSC to suppress T cell responses has been documented; however the mechanisms regulating this suppression remain to be understood. This work proposes a biological dichotomy of MDSC regulated by the tumor microenvironment. In peripheral lymphoid organs MDSC cause T-cell non-responsiveness that is antigen-specific. These MDSC have increased expression of NOX2, enabling them to produce large amounts of reactive oxygen species. Since the transcription factor STAT3 is substantially activated in MDSC, its potential role in upregulation of NOX2 expression was investigated. Over-expression of a constitutively active form of STAT3 increases expression of NOX2 subunits, whereas attenuation of STAT3 activity leads to decreased expression of NOX2. The significance of NOX2 in ROS generation is demonstrated in mice devoid of NOX2 function; NOX2- deficient MDSC are unable to inhibit antigen-induced activation of T cells. In contrast, MDSC within the tumor microenvironment have a diminished potential to generate ROS but acquire expression of arginase and inducible nitric oxide synthase, enzymes plicated in T cell non-responsiveness. Upregulation of these enzymes results in MDSC ability to inhibit lymphocyte response in absence of antigen presentation. The tumor microenvironment also promotes the differentiation of MDSC to tumor associated macrophages. Hypoxia is an exclusive feature to the tumor microenvironment and we investigated its involvement in the properties of MDSC at the tumor site. Exposure of spleen MDSC to hypoxia converts MDSC to non-specific suppressors and induces a preferential differentiation to macrophages. Stabilization of HIF-1!, a transcription factor activated by hypoxia, induces similar changes in MDCS as hypoxic exposure. Finally, ablation of HIF-1! prevents MDSC from acquiring factors that enable the suppression of T cells in absence of antigen. These findings help to expand our understanding of the biology of MDSC and suggest a regulatory pathway of myeloid cell function exclusive to the tumor microenvironment. They may also open new opportunities for therapeutic regulation as we now should take into consideration how systemic location affects the function of MDSC.
58

Changements phénotypiques des cellules endothéliales irradiées au cours du développement des lésions radiques pulmonaires / Phenotypic changes in irradiated endothelial cells and roles in lung injury following radiation therapy

Lavigne, Jérémy 16 October 2017 (has links)
La radiothérapie thoracique peut induire le développement de pneumopathies aiguës et de fibroses. La dysfonction du système vasculaire participe au développement de lésions radiques. Dans l'intestin, un KO endothélial de PAI-1 protège les souris de la fibrose radique. Le premier objectif de ce projet est d'explorer le rôle de PAI-1 dans l'apparition de la fibrose radique pulmonaire. L'irradiation thoracique de souris à 17 Gy altère sévèrement le parenchyme pulmonaire et l'analyse histologique révèle que l'invalidation de PAI-1 aggrave les lésions à 2 et 13 semaines. Cette invalidation ne protège donc pas les animaux des dommages radiques pulmonaires. L'organisation en parallèle du poumon permet d'envisager une tolérance à de fortes doses par fraction sur des petits volumes. Des irradiations en conditions stéréotaxiques ont donc été réalisées chez la souris. Les analyses histologiques montrent une déstructuration alvéolaire et un fort infiltrat inflammatoire au niveau de la zone cible. Un œdème est observable dans l'ensemble du poumon ipsilatéral deux semaines après irradiation. Le poumon ipsilatéral est également affecté par des altérations de structure, tel un épaississement des septa alvéolaires. Ces bouleversements se traduisent également au niveau transcriptomique. A la vue de l'ensemble de ces altérations, un test à l'effort a été réalisé pour évaluer l'impact potentiel sur la fonction pulmonaire. Les résultats mettent en évidence une diminution des performances des animaux. Les analyses sont à approfondir mais elles démontrent l'importance de s'intéresser aux tissus sains situés hors du volume cible mais recevant des fractions variables de la dose délivrée. / Radiation-induced endothelial dysfunction is known to participate to the development of normal tissue damage. PAI- is implicated in the phenotypic changes of irradiated endothelial cells and KOendo mice are protected from radiation damage to the gut. Whole thorax of PAI-1 KOendo and floxed mice were exposed to 17 Gy. Histological analyzes showed that PAI-1 KOendo induces a worsening of injuries at 2 and 13 weeks. Consequently, contrary to the gut no protection from radiation-induced lung damage is observed in PAI-1 KOendo mice. Our second aim was to study the effects of a single high dose stereotactic irradiation on pulmonary tissues. Histological analyzes and scanner imaging show important injuries on the targeted volume. An ipsilateral edema can also be observed 2 weeks after irradiation. Ipsilateral lung is moreover importantly damaged. A thickening of alveolar septa is notably observable. A transcriptomic analysis show important similarities between tissues from the ipsilateral lung and the focal lesion. As really highly damages have been observed in both scanner and histological analyzes, we decided to perform forced physical activity test on treadmill. A drastic decrease of maximal distance traveled has been observed from two weeks. These experiments highlighted a deficiency in respiratory function and all of these results show the importance of non-targeted irradiated pulmonary volume in the development of radiation-induced fibrosis. Effect of an endothelium-specific deletion of HIF-1α has been investigated in this model of stereotactic irradiation. Only few differences have been observed between KOendo and control mice. Experiments are still ongoing.
59

Estudio de las Implicaciones de la Via de Señalización de Notch en Cardioregeneración y Cáncer

González-King Garibotti, Hernán 29 July 2019 (has links)
[ES] Las células de los mamíferos secretan una gran variedad de vesículas extracelulares (EV) que participan activamente en la comunicación celular. Entre ellas, los exosomas son un tipo de EV cuyo tamaño está comprendido entre los 20 y 150 nanómetros que juegan un papel importante en la comunicación celular. De este modo, se ha descrito el papel de los exosomas en distintos procesos como la regeneración de tejidos, la respuesta inmunitaria o en la progresión de diferentes tipos de cánceres. Por otro lado, se ha observado que la actividad de la vía de señalización de Notch juega un papel importante en procesos de diferenciación celular, la angiogénesis o la proliferación, entre otros. Además, se ha relacionado con la aparición y progresión de un gran número de patologías, como el cáncer. Trabajos recientes han advertido que la actividad de la vía de Notch puede regularse mediante un nuevo mecanismo de señalización mediado por exosomas. En este trabajo se profundizó en este nuevo mecanismo de señalización de la vía de Notch en dos contextos diferentes como son las terapias regenerativas y el cáncer. Un trabajo previo de nuestro laboratorio demostró que las células madre mesenquimales (MSC) que mantenían una expresión aumentada del factor inducible por hipoxia 1&#945; (HIF-1&#945;; HIF-MSC) aumentaban el potencial terapéutico de las MSC nativas en un modelo de infarto agudo de miocardio (IAM) en rata a través de un aumento de la angiogénesis y una reducción de la fibrosis. Varios trabajos han estudiado la relación entre la vía de señalización de Notch y HIF-1&#945;; así como la influencia de ambos en el proceso angiogénico. Por estos motivos, en este trabajo nos interesamos por evaluar la relación de ambas vías y su efecto sobre la angiogénesis a través de los exosomas liberados por las HIF-MSC y las MSC. Los resultados permitieron observar que la expresión de HIF-1&#945; indujo un aumento en la secreción y la transferencia de exosomas de MSC a cultivos primarios de células endoteliales. Además, se observó que los exosomas derivados de HIF-MSC tenían un mayor potencial angiogénico tanto in vitro como in vivo en parte debido a una mayor incorporación del ligando de la vía de Notch Jagged1. Se ha observado que los exosomas derivados de células tumorales contribuyen a la progresión tumoral a través de mecanismos como la activación de la transición epitelio mesénquima (EMT), el establecimiento de nichos pre-metastáticos o la inmunomodulación. Así, se sabe que la vía de señalización de Notch es capaz de activar la EMT durante la progresión de distintos tipos de cánceres. Así mismo, los cánceres de mama de peor prognosis han sido relacionados con una desregulación de la vía de señalización de Notch. Por estas razones, nos inquietó la posibilidad de que la señalización de la vía de Notch a través de exosomas estuviera influyendo en la progresión del cáncer de mama. De este modo, estudiamos la presencia de componentes de la vía de señalización de Notch en los exosomas procedentes de dos líneas tumorales de cáncer de mama, una más agresiva (MDA-MB-231) y otra menos agresiva (MCF-7). Así, se observó que varios componentes de Notch se sobreexpresaron en los exosomas procedentes de MDA-MB-231 en comparación con los procedentes de MCF-7. Fue de particular interés la detección del dominio intracelular con actividad transcripcional de Notch1 (N1ICD) sobreexpresado en los exosomas procedentes de MDA-MB-231. Debido a que previamente había sido demostrado que una sobreexpresión de N1ICD en MCF-7 aumentaba su tumorigenicidad a través de una inducción de la EMT, se evaluó el efecto de los componentes de Notch incorporados en los exosomas procedentes de ambas líneas tumorales sobre cultivos de MCF-7. Nuestros resultados sugieren que los componentes de Notch incorporados en los exosomas procedentes de MDA-MB-231 son funcionales y contribuyen a la induc / [CAT] Les cèl·lules dels mamífers secreten una gran varietat de vesícules extracel·lulars (EV) que participen activament en la comunicació celular. Entre elles, els exosomes són un tipus de EV amb una grandària compresa entre els 20 i 150 nanòmetres que juguen un paper important en la comunicació celular. D'aquesta manera, s'ha descrit el paper dels exosomes en diferents processos com la regeneració de teixits, la resposta immunitària o en la progressió de diferents tipus de càncers. D'altra banda, s'ha observat que l'activitat de la via de senyalització de Notch juga un paper molt important en processos de diferenciació cel·lular, la angiogénesis o la proliferació, entre altres. A més, s'ha relacionat amb l'aparició i progressió d'un gran nombre de patologies, com el càncer. Treballs recents han advertit que l'activitat de la via de Notch pot regular-se mitjançant un nou mecanisme de senyalització mediat per exosomes. En aquest treball es va aprofundir en aquest nou de mecanisme de senyalització de la via de Notch en dos contextos diferents com són les teràpies regeneratives i el càncer. Un treball publicat pel nostre equip de treball va demostrar que les cèl·lules mare mesenquimals (MSC) que mantenien una expressió augmentada del factor inducible per hipòxia 1&#945; (HIF-1&#945;; HIF-MSC) augmentaven el potencial terapèutic de les MSC natives en un model d'infart agut de miocardi (IAM) en rata a través d'un augment de la angiogénesis i una reducció de la fibrosi. Diversos treballs han estudiat la relació entre la via de senyalització de Notch i HIF-1&#945;; així com la influència de tots dos en el procés angiogénic. Per aquests motius, en aquest treball ens vam interessar en estudiar la relació de totes dues vies i el seu efecte sobre la angiogénesis a través dels exosomes alliberats per les HIF-MSC i les MSC. Els resultats van permetre observar que l'expressió de HIF-1&#945; va induir un augment en la secreció i la transferència d'exosomes de MSC a cultius primaris de cèl·lules endotelials. A més, es va observar que els exosomes derivats de HIF-MSC tenien un major potencial angiogénic tant in vitro com in vivo en part a causa d'una major incorporació del lligant de la via de Notch Jagged1. S'ha observat que els exosomes procedents de cèl·lules tumorals contribueixen a la progressió tumoral a través de mecanismes com l'activació de la transició epiteli mesènquima (EMT), l'establiment de nínxols pre-metastàtics o la inmunomodulació. En aquest sentit, se sap que la via de senyalització de Notch és capaç d'activar l'EMT durant la progressió de diferents tipus de càncers. Així mateix, els càncers de mama de pitjor prognosi han sigut reiteradament relacionats amb una desregulació de la via de senyalització de Notch. Per açò, ens va inquietar la possibilitat que la senyalització de la via de Notch a través d'exosomes estiguera influint en la progressió del càncer de mama. D'aquesta manera, estudiem la presència de components de la via de senyalització de Notch en els exosomes procedents de dues línies tumorals de càncer de mama, una més agressiva (MDA-MB-231) i una altra menys agressiva (MCF-7). Així, es va observar que diversos components de Notch es sobreexpresaben en els exosomes procedents de MDA-MB-231 en comparació amb els procedents de MCF-7. Va ser de particular interés la detecció del domini intracel·lular amb activitat transcripcional de Notch1 (N1ICD) sobreexpresat en els exosomes procedents de MDA-MB-231. Debut a que havia sigut demostrat que una sobreexpressió de N1ICD en MCF-7 augmentava la seua tumorigenicidad a través d'una inducció de l'EMT, es va evaluar l'efecte dels components de Notch incorporats en els exosomes procedents de les dues línies tumorals sobre cultius de MCF-7. Els nostres resultats suggereixen que els components de Notch incorporats en els exosomes procedents de MDA-MB-231 eren funcionals i contribuïen a la / [EN] Mammal cells secrete a great variety of extracellular vesicles (EV) that actively participate in intercellular communication. Among them, exosomes are a type of EV whose size is between 20 and 150 nanometers and play an important role in intercellular communication. In this way, the role of exosomes in different processes such as tissue regeneration, the immune response or in the progression of different types of cancers has been described. On the other hand, it has been observed that the Notch signaling pathway plays a very important role in processes such as cell differentiation, angiogenesis or proliferation, among others. In addition, it has been related to the appearance and progression of a large number of pathologies, such as cancer. Recent works have shown that the activity of the Notch pathway can be regulated by a new signaling mechanism mediated by exosomes. In this work, we deepened this new signaling mechanism of the Notch signaling pathway in two different contexts: the regenerative therapies and cancer. A work previously published by our laboratory showed that mesenchymal stem cells (MSC) that maintained an increased expression of hypoxia-inducible factor 1&#945; (HIF-1&#945;; HIF-MSC) increased the therapeutic potential of native MSC in a model of acute myocardial infarction (AMI) in rats through an increase in angiogenesis and a reduction in fibrosis. Several studies have studied the relationship between the Notch signaling pathway and HIF-1&#945; as well as the influence of both in the angiogenic process. For these reasons, in this work we were interested in evaluating the relationship of both pathways and their effect on angiogenesis through exosomes released by HIF-MSCs and MSCs. The results showed that the expression of HIF-1&#945; induced an increase in the secretion and the transfer of exosomes of MSC to primary cultures of endothelial cells. In addition, it was observed that exosomes derived from HIF-MSC had a greater angiogenic potential both in vitro and in vivo in part due to a greater incorporation of the Notch ligand Jagged1. In the last decade, it has been observed that exosomes from tumor cells contribute to tumor progression through mechanisms such as the activation of epithelial to mesenchymal transition (EMT), the establishment of pre-metastatic niches orimmunomodulation. In this sense, it is known that the Notch signaling pathway is capable of activating EMT during the progression of different types of cancers. Likewise, breast cancers of bad prognosis have been repeatedly related to a deregulation of the Notch signaling pathway. For these reasons, we were concerned about the possibility that the signaling of the Notch pathway through exosomes was influencing the progression of breast cancers. In this way, we studied the presence of Notch signaling pathway components in exosomes from the metastatic and more aggressive MDA-MB-231 and the non-metastatic and less aggressive MCF-7 cell lines. It was observed that several Notch components were overexpressed in exosomes from MDA-MB-231 compared to those from MCF-7. Of particular interest was the detection of the intracellular domain with transcriptional activity of Notch1 (N1ICD) overexpressed in MDA-MB-231 exosomes. It has been previously demonstrated that an overexpression of N1ICD in MCF-7 increases its tumorigenicity through an induction of EMT. Because of this, we evaluated the effect of Notch components incorporated in exosomes from both tumoral cell lines on MCF-7 cultures. Our results suggested that Notch components incorporated into MDA-MB-231 exosomes were functional and contributed to the induction of EMT when added to MCF-7 cultures in part due to N1ICD activity. / González-King Garibotti, H. (2019). Estudio de las Implicaciones de la Via de Señalización de Notch en Cardioregeneración y Cáncer [Tesis doctoral no publicada]. Universitat Politècnica de València. https://doi.org/10.4995/Thesis/10251/124343 / TESIS
60

Dendritic Cell-Derived TSLP Negatively Regulates HIF-1α and IL-1β during Dectin-1 signaling

Elder, Matthew J., Webster, Steve J., Fitzmaurice, Timothy J., Shaunak, Aran S.D., Steinmetz, Martin, Chee, Ronnie, Mallat, Ziad, Suzanne Cohen, E., Williams, David L., Hill Gaston, J. S., Goodall, Jane C. 01 January 2019 (has links)
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. Thymic stromal lymphopoietin (TSLP) is a functionally pleotropic cytokine important in immune regulation, and TSLP dysregulation is associated with numerous diseases. TSLP is produced by many cell types, but has predominantly been characterized as a secreted factor from epithelial cells which activates dendritic cells (DC) that subsequently prime T helper (TH) 2 immunity. However, DC themselves make significant amounts of TSLP in response to microbial products, but the functional role of DC-derived TSLP remains unclear. We show that TSLPR signaling negatively regulates IL-1β production during dectin-1 stimulation of human DC. This regulatory mechanism functions by dampening Syk phosphorylation and is mediated via NADPH oxidase-derived ROS, HIF-1α and pro-IL-1β expression. Considering the profound effect TSLPR signaling has on the metabolic status and the secretome of dectin-1 stimulated DC, these data suggest that autocrine TSLPR signaling could have a fundamental role in modulating immunological effector responses at sites removed from epithelial cell production of TSLP.

Page generated in 0.0508 seconds